Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines.
Since the introduction of cisplatin into the clinic, the treatment of patients with a variety of solid tumors including testicular germ cell tumors, ovarian and lung cancers, has dramatically improved. One of the main causes for therapeutic failure in these malignancies is the development of drug re...
Principais autores: | Noel, E, Perry, J, Chaplin, T, Mao, X, Cazier, J, Joel, S, Oliver, RT, Young, B, Lu, Y |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2008
|
Registros relacionados
-
Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors
por: André van Helvoort Lengert, et al.
Publicado em: (2022-08-01) -
Immunotherapy in Testicular Germ Cell Tumors
por: Katarina Kalavska, et al.
Publicado em: (2020-09-01) -
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
por: Meineke Viktor, et al.
Publicado em: (2011-05-01) -
p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.
por: Matthias Gutekunst, et al.
Publicado em: (2011-01-01) -
Integrated Molecular Characterization of Testicular Germ Cell Tumors
por: Hui Shen, et al.
Publicado em: (2018-06-01)